Skip to main content
Figure 2 | Critical Care

Figure 2

From: Cyclic arginine-glycine-aspartate attenuates acute lung injury in mice after intestinal ischemia/reperfusion

Figure 2

cRGD improves microscopic deterioration of the lungs after intestinal ischemia/reperfusion. (A) Lung tissues harvested 4 hours after intestinal ischemia/reperfusion (I/R) were stained with H & E, and examined under light microscopy at 200× magnification. Representative images for sham, vehicle, and cyclic arginine-glycine-aspartate peptide (cRGD) treatment groups. (B) Histologic injury scores of the lungs in different groups were quantified as described in Materials and methods. (C) Lung tissue myeloperoxidase (MPO) activity was determined spectrophotometrically. Data expressed as mean ± standard error (n = 5/group). *P < 0.05 versus sham, #P < 0.05 versus vehicle. ND, nondetectable.

Back to article page